These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8549386)

  • 1. Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
    Nouvet G; Benmessaoud K
    Drugs; 1995; 49 Suppl 2():423-5. PubMed ID: 8549386
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
    Marcos Sánchez F; Reinoso Cobo D; García Camba L; Celdrán Gil JL
    An Med Interna; 1995 Mar; 12(3):150-1. PubMed ID: 7795125
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; Schreurs A; Siami G; Barkman HW; Anzueto A; Shan M; Moesker H; Stack T; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):730-8. PubMed ID: 9798025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
    Pryka R; Kowalsky S; Haverstock D
    Clin Ther; 1998; 20(1):141-55. PubMed ID: 9522111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefixime therapy in sinusitis].
    Jorde W; Schata M
    Infection; 1990; 18 Suppl 3():S129-31. PubMed ID: 2079372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
    Lorenz J
    Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
    Wilton LV; Pearce GL; Mann RD
    Br J Clin Pharmacol; 1996 Apr; 41(4):277-84. PubMed ID: 8730972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
    Matthews BL; Kohut RI; Edelstein DR; Rybak LP; Rapp M; McCaffrey TV; Kimmelman CP; Parnes SM; Marinaccio AT; Kohlbrenner VM
    South Med J; 1993 Mar; 86(3):329-33. PubMed ID: 8451674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefixime therapy in patients with proven gonorrhea].
    Backhaus A; Tinzl J
    Infection; 1990; 18 Suppl 3():S145-6. PubMed ID: 2079375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of ciprofloxacin in the treatment of chronic bronchitis].
    Zuck P
    Presse Med; 1998 Mar; 27(12):594-6. PubMed ID: 9767959
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
    Modai J
    Presse Med; 1989 Oct; 18(32):1605-7. PubMed ID: 2530543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results using cefixime for bacterial respiratory tract infections].
    Leonhardt L
    Infection; 1990; 18 Suppl 3():S115-8. PubMed ID: 2079368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of cefixime (results of multicenter trials)].
    Sereda EV; Gusel' VA; Feshchenko IuI; Ustinovich AK; Zubovich VK; Trofimov VI; Nedostup AV; Ovchinnikov IuM; Pluzhnikov MS; Darenkov AF
    Antibiot Khimioter; 1993 Jun; 38(6):45-50. PubMed ID: 8166566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral treatment of gonorrhea and chlamydia.
    Loughlin KA; Bakst CM; Rybak MJ
    Ann Pharmacother; 1994 May; 28(5):600-2. PubMed ID: 8068998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
    Theopold M; Benner U; Bauernfeind A
    Infection; 1990; 18 Suppl 3():S122-4. PubMed ID: 2079370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
    Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.